Retrospective examination of selected outcomes of Medicines Use Review (MUR) services in New Zealand
- 343 Downloads
Background Poor adherence to medication can lead to suboptimal outcomes, and is reported to occur frequently. Pharmacists in some countries are funded to support the appropriate use of medications in patients and enhance medication adherence, by providing services such as Medicines Use Review (MUR). Objective To describe and investigate factors that may influence patients’ knowledge and perceptions of and adherence to medications as determined during MUR. Setting Community pharmacies in a locality in New Zealand. Method Following consent from five MUR service providers, records of patients’ MUR consultations conducted between November 2007 and December 2011 were retrospectively reviewed for information on patients, services, and outcomes. Using multilevel mixed-effects logistic regression, factors that predicted the providers’ score of the patients’ medication knowledge, and the patients’ score of their adherence to and perceptions of medications, were investigated. Main outcome measure patients’ knowledge, perceptions and adherence scores. Results A total of 353 MUR patients’ records were evaluated. The median (IQR) age of patients was 73 (63–81) years. About 41.1 % of patients were Māori. A total of 204 (57.8 %) patients had two MUR consultations and only 53 (15 %) had four. The mean score of patients’ knowledge, perceptions of, and adherence to medications were found to increase in each visit which suggests that adherence support by pharmacists might improve patients’ outcomes. Females had higher medication knowledge scores than males (OR 3.09, 95 % CI 1.29–7.44). There was some evidence to suggest Māori had lower scores for knowledge of medications than non-Māori (OR 0.092, 95 % CI 0.02–0.36). In addition, longer duration in the program predicted better scores for medication knowledge, adherence and perceptions of medications. Conclusions MUR was found to have the potential to improve the scores of patients’ knowledge and perceptions of and adherence to medicines, and factors such as gender, ethnicity and longer duration in the services were found to predict these outcomes.
KeywordsCommunity pharmacy services Medication adherence Medication knowledge Medication review New Zealand Pharmaceutical care services Pharmacists
We would like to thank the MUR coordinator and the community pharmacists who participated in this study and helped us with the data collections.
Funding for this study was provided by the School of Pharmacy, University of Otago. EH was supported by scholarship from Universiti Kebangsaan Malaysia and Ministry of Higher Education Malaysia.
Conflicts of interest
None to declare.
- 2.World Health Organization. Adherence to long-term therapies: evidence for action, 2003. [cited 2013 Aug 24]. http://www.who.int/chp/knowledge/publications/adherence_report/en/.
- 3.New England Health Institute. Thinking outside the pillbox: A system-wide approach to improving patient medication adherence for chronic disease, 2009. [cited 2013 Aug 24]. http://www.nehi.net/publications/44/thinking_outside_the_pillbox_a_systemwide_approach_to_improving_patient_medication_adherence_for_chronic_disease.
- 5.Clyne W, Blenkinsopp A and Seal R. A Guide to Medication Review, 2008. [cited 2013 Aug 24]. http://www.npc.nhs.uk/review_medicines/intro/resources/agtmr_web1.pdf.
- 6.District Health Board New Zealand. New Zealand National Pharmacist Services Framework, 2007. [cited 2013 Aug 24]. http://www.psnz.org.nz/public/cop/documents/dhbnzpharmacistservicesframework2007.pdf.
- 7.District Health Board Shared Services. New Zealand National Pharmacist Services Framework, 2007. [cited 2013 Aug 24]. http://www.dhbsharedservices.health.nz/Site/SIG/NPSF/NPSF-Framework.aspx.
- 8.Brandt T, Harrison J, Sheridan J, Shaw J, Jensen M. The evaluation of auckland District Health Board’s medicines use review pilot: the ADMiRE Report, 2009. [cited 2013 Aug 24]. http://www.adhb.govt.nz/PHO/documents/ADMiRE%20report%20final.pdf.
- 9.Lee E, Braund R, Tordoff J. Examining the first year of medicines use review services provided by pharmacist in New Zealand. N Z Med J. 2009;122(1293):26–35.Google Scholar
- 10.Cipolle R, Strand L, Morley P. Pharmaceutical care practice: the patient centered approach to medication management. 3rd ed. The United States of America: McGraw-Hill companies; 2012. ISBN 978-0-07-179086-4.Google Scholar
- 12.Statistics New Zealand, 2006 Census. [cited 2013 Aug 24]. http://www.stats.govt.nz/Census/2006CensusHomePage.aspx.
- 13.Hatah E, Tordoff J, Duffull S, Braund R. Pharmacists’ performance of clinical interventions during adherence support medication reviews. Res in Soc and Admin Pharm (article in press). http://dx.doi.org/10.1016/j.sapharm.2013.04.008.
- 14.StataCorp. Stata Statistical Software: Release 12, StataCorp LP2011: College Station, TX.Google Scholar
- 25.Ministry of Health New Zealand. Health literacy and Maori results from the 2006 adult literacy and life skills survey. [cited 2013 Aug 24]. http://www.health.govt.nz/publication/korero-marama-health-literacy-and-maori-results-2006-adult-literacy-and-life-skills-survey.
- 26.Erickson S, Slaughter R, Halapy H. Pharmacists’ ability to influence outcomes of hypertension therapy. Pharmacother. 1997;17(1):140–7.Google Scholar
- 29.Coulter A, Parsons S and Askham J. Policy brief: where are the patients in decision-making about their own care?, 2008. [cited 2013 Aug 24]. http://www.who.int/management/general/decisionmaking/WhereArePatientsinDecisionMaking.pdf.
- 30.Fairman K and Motheral B. Evaluating medication adherence: which measure is right for your program? J Managed Care Pharmacy. 2000;6(6):499-504.Google Scholar